Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a new sedative make bronchoscopy safer and smoother?

NCT ID NCT07744061

Symptom relief Sponsor: Wenzhou Central Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests whether ciprofol, a newer sedative, provides better and safer sedation than the standard drug propofol for people undergoing bronchoscopy, a procedure to examine the airways. Both are given with a low dose of sufentanil for pain relief. The study involves 100 adults aged 35 to 65 with mild or no systemic disease, randomly assigned to receive one of the two sedatives. Researchers will measure the total sedative dose needed, side effects like breathing or blood pressure changes, and how quickly patients wake up and recover.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ciprofol (an intravenous sedative) compared with propofol, both combined with low-dose sufentanil
What this could lead to
If ciprofol works better, it could offer a safer, more comfortable sedation option for bronchoscopy, with fewer breathing or blood pressure problems.
What could go wrong
This is a small, early-stage comparison. Ciprofol may not prove superior to propofol, and any sedative carries risks like breathing suppression or low blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

100 people

The number who actually took part.

Started

Aug 2022

Finished

Dec 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 35 to 65 years. * Body weight 45 to 80 kg. * American Society of Anesthesiologists physical status I or II. * Scheduled to undergo painless bronchoscopy. * No contraindications to intravenous anesthesia. * Willing and able to cooperate with study procedures. * Provided written informed consent. Exclusion Criteria: * Body mass index greater than 40 kg/m². * Uncontrolled hypertension, defined as systolic blood pressure greater than 180 mmHg. * Severe cardiac arrhythmia. * Unstable angina. * Acute myocardial infarction within the previous 3 months. * Acute exacerbation of asthma. * Moderate to severe chronic obstructive pulmonary disease. * Known allergy or hypersensitivity to any study anesthetic medication. * Full-stomach status, intestinal obstruction, or gastric retention. * Coagulation dysfunction or a clinically significant bleeding tendency. * Mental illness or cognitive impairment that prevented cooperation with study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bronchoscopy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bronchoscopy Procedural sedation

Contacts and locations

Locations

  • Wenzhou Central Hospital

    Wenzhou, Zhejiang, 325000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.